6-29659536-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6BP7BS1BS2
The NM_206809.4(MOG):āc.306A>Gā(p.Lys102=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0125 in 1,613,114 control chromosomes in the GnomAD database, including 170 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (no stars).
Frequency
Genomes: š 0.0087 ( 8 hom., cov: 31)
Exomes š: 0.013 ( 162 hom. )
Consequence
MOG
NM_206809.4 synonymous
NM_206809.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0190
Genes affected
MOG (HGNC:7197): (myelin oligodendrocyte glycoprotein) The product of this gene is a membrane protein expressed on the oligodendrocyte cell surface and the outermost surface of myelin sheaths. Due to this localization, it is a primary target antigen involved in immune-mediated demyelination. This protein may be involved in completion and maintenance of the myelin sheath and in cell-cell communication. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.6).
BP6
Variant 6-29659536-A-G is Benign according to our data. Variant chr6-29659536-A-G is described in ClinVar as [Likely_benign]. Clinvar id is 3056332.Status of the report is no_assertion_criteria_provided, 0 stars.
BP7
Synonymous conserved (PhyloP=-0.019 with no splicing effect.
BS1
Variant frequency is greater than expected in population mid. gnomad4_exome allele frequency = 0.0129 (18796/1460778) while in subpopulation MID AF= 0.021 (121/5768). AF 95% confidence interval is 0.0179. There are 162 homozygotes in gnomad4_exome. There are 9352 alleles in male gnomad4_exome subpopulation. Median coverage is 31. This position pass quality control queck.
BS2
High AC in GnomAd4 at 1327 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MOG | NM_206809.4 | c.306A>G | p.Lys102= | synonymous_variant | 2/8 | ENST00000376917.8 | NP_996532.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MOG | ENST00000376917.8 | c.306A>G | p.Lys102= | synonymous_variant | 2/8 | 1 | NM_206809.4 | ENSP00000366115 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00873 AC: 1329AN: 152218Hom.: 8 Cov.: 31
GnomAD3 genomes
AF:
AC:
1329
AN:
152218
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00955 AC: 2356AN: 246652Hom.: 25 AF XY: 0.0102 AC XY: 1369AN XY: 134424
GnomAD3 exomes
AF:
AC:
2356
AN:
246652
Hom.:
AF XY:
AC XY:
1369
AN XY:
134424
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0129 AC: 18796AN: 1460778Hom.: 162 Cov.: 31 AF XY: 0.0129 AC XY: 9352AN XY: 726706
GnomAD4 exome
AF:
AC:
18796
AN:
1460778
Hom.:
Cov.:
31
AF XY:
AC XY:
9352
AN XY:
726706
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00871 AC: 1327AN: 152336Hom.: 8 Cov.: 31 AF XY: 0.00820 AC XY: 611AN XY: 74498
GnomAD4 genome
AF:
AC:
1327
AN:
152336
Hom.:
Cov.:
31
AF XY:
AC XY:
611
AN XY:
74498
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
10
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
MOG-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 14, 2020 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at